X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (28) 28
humans (24) 24
female (20) 20
hematology (20) 20
male (20) 20
middle aged (18) 18
adult (16) 16
aged (16) 16
oncology (11) 11
prognosis (10) 10
stem-cell transplantation (10) 10
abridged index medicus (8) 8
amyloidosis - genetics (8) 8
cancer (8) 8
chromosome aberrations (8) 8
diagnosis (8) 8
multiple-myeloma (8) 8
acute myeloid leukemia (7) 7
aged, 80 and over (7) 7
aml (7) 7
chemotherapy (7) 7
disease-free survival (7) 7
mutation (7) 7
adolescent (6) 6
al amyloidosis (6) 6
leukemia (6) 6
leukemia, myeloid, acute - mortality (6) 6
retrospective studies (6) 6
young adult (6) 6
amyloidosis - mortality (5) 5
analysis (5) 5
in situ hybridization, fluorescence (5) 5
in-situ hybridization (5) 5
light-chain amyloidosis (5) 5
primary systemic amyloidosis (5) 5
survival rate (5) 5
amyloidosis - diagnosis (4) 4
amyloidosis - drug therapy (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
article (4) 4
cancer of unknown primary (4) 4
impact (4) 4
leukemia, myeloid, acute - genetics (4) 4
staging system (4) 4
stem cells (4) 4
survival (4) 4
survival analysis (4) 4
bortezomib (3) 3
brain natriuretic peptide (3) 3
chromosomal-abnormalities (3) 3
dexamethasone - therapeutic use (3) 3
genetic abnormalities (3) 3
genomic instability (3) 3
immunoglobulin light chains - metabolism (3) 3
immunoglobulin light-chain amyloidosis - drug therapy (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
leukemia, myeloid, acute - pathology (3) 3
leukemia, myeloid, acute - therapy (3) 3
monosomal karyotype (3) 3
myeloid leukemia (3) 3
plasma cell disorders (3) 3
primary site (3) 3
translocation, genetic (3) 3
transplantation (3) 3
treatment outcome (3) 3
abnormalities (2) 2
adults (2) 2
alleles (2) 2
allogeneic transplantation (2) 2
aml patients (2) 2
amyloidosis - blood (2) 2
amyloidosis - immunology (2) 2
amyloidosis - metabolism (2) 2
animals (2) 2
antibodies (2) 2
antineoplastic agents, alkylating - therapeutic use (2) 2
bendamustine hydrochloride - therapeutic use (2) 2
bone marrow (2) 2
bone marrow - pathology (2) 2
boronic acids - therapeutic use (2) 2
carcinoma (2) 2
cardiac biomarkers (2) 2
care and treatment (2) 2
cd34 antigen (2) 2
cell division (2) 2
cell line, tumor (2) 2
chromosomes (2) 2
chromosomes, human, pair 11 (2) 2
chromosomes, human, pair 4 (2) 2
clonal relationship (2) 2
cohort studies (2) 2
complex aberrant karyotype (2) 2
conventional care regimens (2) 2
cyclophosphamide (2) 2
cytarabine (2) 2
dexamethasone (2) 2
diseases (2) 2
flow cytometry (2) 2
follow-up studies (2) 2
genetic aspects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Deutsches Aerzteblatt Online, ISSN 1866-0452, 04/2019
Journal Article
Deutsches Arzteblatt international, 04/2019, Volume 116, Issue 14, p. 251
Journal Article
Deutsches Ärzteblatt International, 4/2019, Volume 116, Issue 14, pp. 251 - 251
Journal Article
Recent Results in Cancer Research, ISSN 0080-0015, 2018, Volume 212, pp. 187 - 197
Enasidenib is an orally available, selective, potent, small molecule inhibitor of mutant isocitrate dehydrogenase 2 (IDH2). Neomorphic mutations in IDH2 are... 
AML | AG-221 | Glioblastoma | Ketoglutarate | 2-hydroxyglutarate | Hypermethylation | IDH | Acute myeloid leukemia | Isocitrate dehydrogenase | Triazines - pharmacology | Animals | Aminopyridines - pharmacology | Humans | Leukemia, Myeloid, Acute - drug therapy | Antineoplastic Agents - pharmacology | Mice | Mutation | Isocitrate Dehydrogenase - antagonists & inhibitors
Journal Article
Leukemia, ISSN 0887-6924, 08/2019, Volume 33, Issue 11, pp. 2619 - 2627
Abnormal karyotypes are common in cancer cells and frequently observed in acute myeloid leukemia (AML), in which complex karyotype aberrations are associated... 
Myeloid cells | Structural stability | Myeloid leukemia | Leukemia | p53 Protein | Abnormalities | Karyotypes | Aneuploidy | Genomic instability | Heterogeneity | Aberration | Mutation | Acute myeloid leukemia | Chromosomes | Chromosome aberrations | Deoxyribonucleic acid--DNA
Journal Article
Der Onkologe, ISSN 0947-8965, 12/2017, Volume 23, Issue 12, pp. 1000 - 1005
Beim CUP-Syndrom („cancer of unknown primary“) handelt es sich um eine Tumorerkrankung, bei der eine Metastasierung klinisch und histologisch gesichert ist,... 
Antikörper | Mutationsanalyse | Medicine & Public Health | Mutational profiling | Targeted therapy | Antibodies | Oncology | Panel sequencing | Cancer of unknown primary | Panelsequenzierung | Zielgerichtete Therapie
Journal Article
Der Onkologe, ISSN 0947-8965, 12/2017, Volume 23, Issue 12
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00761-017-0206-x... 
Viral antibodies | Chemotherapy | Antibodies | Health aspects | Cancer
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2019, Volume 9, Issue MAY, p. 402
Journal Article
Seminars in diagnostic pathology, ISSN 0740-2570, 11/2017
In cancer of unknown primary (CUP), metastases are clinically and histologically confirmed, but the primary tumor site remains elusive after extensive work-up.... 
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2019, Volume 145, Issue 11, pp. 2963 - 2973
Cancer of unknown primary (CUP) denotes cancer cases where metastatic spread is histologically confirmed, but no respective primary tumor can be identified.... 
clonal relationship | cancer of unknown primary | metastasis | germline mutation | next‐generation sequencing | Gene mutations | Genetic research | Metastasis | Diagnosis | Comparative analysis | Racial profiling | Formaldehyde | Paraffins | Profiling | Decision making | Histology | Breast cancer | Malignancy | Paraffin | Metastases | Mutation | Cancer | Tumors
Journal Article
Journal Article
Genes, Chromosomes and Cancer, ISSN 1045-2257, 06/2019, Volume 58, Issue 6, pp. 392 - 395
Journal Article
Seminars in Diagnostic Pathology, ISSN 0740-2570, 05/2018, Volume 35, Issue 3, pp. 199 - 206
Journal Article
European Journal of Haematology, ISSN 0902-4441, 11/2017, Volume 99, Issue 5, pp. 392 - 398
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 04/2019, Volume 12, Issue 1, pp. 44 - 10
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 187 - 187
Abstract INTRODUCTION. Systemic light chain amyloidosis (AL) is caused by accumulation of plasma cells producing misfolded monoclonal light chains depositing... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.